Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 25, 2025
Development of a Patient-Reported Outcome Measure of Side Effects for Patients Taking Calcineurin Inhibitors: The FACIT-CNI-Ntx
Courtney N Hurt, George J Greene, John Friedewald, et al.
Journal of Patient-Reported Outcomes
|
January 7, 2026
Development of a conceptual model of BKV impacts on health-related quality of life in kidney transplant recipients: a qualitative study
Courtney N Hurt, Maja Kuharic, Sara Shaunfield, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 15, 2021
Technique for inguino-femoral lymph node dissection in vulvar cancer: an international survey
Sadie Esme Fleur Jones, Pedro T Ramirez, Geetu Prakash Bhandoria, et al.
The Lancet. Oncology
|
October 12, 2014
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial
Amanda Tristram, Christopher N Hurt, Tracie Madden, et al.
BMC Cancer
|
November 1, 2011
SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
Christopher N Hurt, Lisette S Nixon, Gareth O Griffiths, et al.
The Journal of Infectious Diseases
|
August 1, 1996
Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum
P L Alonso, T A Smith, J R Armstrong-Schellenberg, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
October 10, 2024
Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma: Secondary Analysis of the PATHOS Randomized Clinical Trial
James T O'Hara, Christopher N Hurt, Kate Ingarfield, et al.
British Journal of Cancer
|
February 15, 2017
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer
T Crosby, C N Hurt, S Falk, et al.
Glomerular Diseases
|
May 11, 2026
Clinical Outcome Assessment Endpoints in Nephrotic Syndrome Drug Development: Research Partner Feedback on Patient-Centered Trial Design
John Devin Peipert, Maja Kuharic, Noelle E Carlozzi, et al.
Lancet (London, England)
|
December 16, 2014
Effect of early neonatal vitamin A supplementation on mortality during infancy in Ghana (Neovita): a randomised, double-blind, placebo-controlled trial
Karen M Edmond, Sam Newton, Caitlin Shannon, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 25, 2025
Development of a Patient-Reported Outcome Measure of Side Effects for Patients Taking Calcineurin Inhibitors: The FACIT-CNI-Ntx
Courtney N Hurt, George J Greene, John Friedewald, et al.
Journal of Patient-Reported Outcomes
|
January 7, 2026
Development of a conceptual model of BKV impacts on health-related quality of life in kidney transplant recipients: a qualitative study
Courtney N Hurt, Maja Kuharic, Sara Shaunfield, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 15, 2021
Technique for inguino-femoral lymph node dissection in vulvar cancer: an international survey
Sadie Esme Fleur Jones, Pedro T Ramirez, Geetu Prakash Bhandoria, et al.
The Lancet. Oncology
|
October 12, 2014
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial
Amanda Tristram, Christopher N Hurt, Tracie Madden, et al.
BMC Cancer
|
November 1, 2011
SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
Christopher N Hurt, Lisette S Nixon, Gareth O Griffiths, et al.
The Journal of Infectious Diseases
|
August 1, 1996
Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum
P L Alonso, T A Smith, J R Armstrong-Schellenberg, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
October 10, 2024
Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma: Secondary Analysis of the PATHOS Randomized Clinical Trial
James T O'Hara, Christopher N Hurt, Kate Ingarfield, et al.
British Journal of Cancer
|
February 15, 2017
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer
T Crosby, C N Hurt, S Falk, et al.
Glomerular Diseases
|
May 11, 2026
Clinical Outcome Assessment Endpoints in Nephrotic Syndrome Drug Development: Research Partner Feedback on Patient-Centered Trial Design
John Devin Peipert, Maja Kuharic, Noelle E Carlozzi, et al.
Lancet (London, England)
|
December 16, 2014
Effect of early neonatal vitamin A supplementation on mortality during infancy in Ghana (Neovita): a randomised, double-blind, placebo-controlled trial
Karen M Edmond, Sam Newton, Caitlin Shannon, et al.
Page
of 5